KEGG   DRUG: Abacavir - lamivudine - zidovudine mixtHelp
Entry
D10838            Mixture   Drug                                   

Name
Abacavir - lamivudine - zidovudine mixt;
Trizivir (TN)
Product
  Generic
Component
(Abacavir sulfate [DR:D00891] | Abacavir [DR:D07057] | Abacavir succinate [DR:D02734]), Lamivudine [DR:D00353], Zidovudine [DR:D00413]
Remark
ATC code: J05AR04
Product: D10838<US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR04 Zidovudine, lamivudine and abacavir
      D10838  Abacavir - lamivudine - zidovudine mixt <US>
Antiinfectives [br08350.html]
 Antivirals
  D10838
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10838
BRITE hierarchy
Other DBs
PubChem: 319902638
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system